Hydrocortisone for Persistent Hypoglycemia in Newborns
Hydrocortisone should be reserved for newborns with confirmed adrenal insufficiency or hyperinsulinism unresponsive to adequate glucose infusion (typically >12-15 mg/kg/min), and should NOT be used routinely for transient neonatal hypoglycemia.
When to Consider Hydrocortisone
The evidence does not support routine hydrocortisone use for simple neonatal hypoglycemia. However, hydrocortisone has specific indications:
Primary Indication: Suspected Adrenal Crisis
If a newborn presents with persistent hypoglycemia accompanied by hemodynamic instability, hyponatremia, hyperkalemia, or circulatory collapse, suspect adrenal insufficiency and treat immediately 1, 2.
Secondary Consideration: Refractory Hyperinsulinism
While the primary treatment for hyperinsulinism is diazoxide 3, hydrocortisone may be considered if hypoglycemia persists despite adequate glucose infusion rates and other interventions have failed.
Recommended Dosing Regimen
For Suspected Adrenal Crisis in Newborns:
- Dose: 2 mg/kg every 6 hours IV (can also be given IM or SC) 1
- Route: IV drip preferred, or IM/SC injection every 6-8 hours
- Concurrent therapy:
- 10% glucose infusion for hypoglycemia
- Fluid volume: 150-180 mL/kg/day for newborns
- NaCl provision: 10-15 mEq/kg/day 1
For Confirmed Adrenal Insufficiency (Maintenance):
- Neonatal period: 20-40 mg/m²/day during the first month, then reduce to 10-18 mg/m²/day 1
- Divided doses: 3 times daily in newborns and young children 1
Critical Caveats and Pitfalls
Do NOT Use Hydrocortisone Routinely
The evidence shows hydrocortisone can increase blood glucose in small-for-gestational-age infants 4, 5, but this does not justify its routine use. Research demonstrates it reduces peripheral glucose utilization and may increase infection risk 6.
Avoid in Perinatal Stress-Induced Hypoglycemia
For hypoglycemia due to perinatal stress (prematurity, SGA, infant of diabetic mother), avoid hydrocortisone for the first 7-10 days if euglycemia can be maintained by other means 3. These infants typically have transient hyperinsulinism that resolves spontaneously.
First Optimize Glucose Delivery
Before considering hydrocortisone:
- Ensure adequate glucose infusion rate (start 4-8 mg/kg/min in preterm, 2.5-5 mg/kg/min in term newborns) 7
- Target glucose >2.5 mmol/L (45 mg/dL) to avoid harm 7, 8
- Maximum glucose infusion typically 12 mg/kg/min before considering other interventions 7
Monitor for Adverse Effects
Hydrocortisone in extremely preterm infants may increase risk of:
- Sepsis (especially <26 weeks gestation) 6
- Gastrointestinal perforation (particularly with concurrent indomethacin) 6
- Hyperglycemia (monitor blood glucose closely) 7
Diagnostic Workup Before Treatment
If considering hydrocortisone for persistent hypoglycemia:
- Draw critical sample during hypoglycemia: cortisol, ACTH, insulin, C-peptide, growth hormone 2
- Assess for adrenal insufficiency: Check electrolytes (hyponatremia, hyperkalemia suggest adrenal crisis) 1, 2
- Evaluate for hyperinsulinism: Inappropriately elevated insulin during hypoglycemia 3
Clinical Monitoring Required
- Blood pressure, heart rate, urine output, alertness 1
- Blood glucose every 1-2 hours initially 7
- Electrolytes (sodium should not increase >1 mEq/kg/hr) 1
Treatment Algorithm
- Immediate: IV glucose bolus 0.5-1 g/kg (2-4 mL/kg D25W or 5-10 mL/kg D10W) 2
- Maintenance: Start glucose infusion 4-8 mg/kg/min (preterm) or 2.5-5 mg/kg/min (term) 7
- If persistent despite adequate glucose: Consider underlying cause
- Duration: Continue until clinical stability (24-48 hours for adrenal crisis) 1
The key principle: Hydrocortisone is NOT a first-line treatment for neonatal hypoglycemia but rather a specific therapy for adrenal insufficiency or as adjunctive treatment in refractory hyperinsulinism after consultation with pediatric endocrinology.